Showing results (1211-1220 of 1,350) with videos related to

Sort By:
Pageof 135
The Journal of Infectious Diseases|October 25, 2023
Inhibition of the Lectin Pathway of Complement Activation Reduces Acute Respiratory Distress Syndrome Severity in a Mouse Model of SARS-CoV-2 InfectionYoussif M Ali, George W Carnell, Stefano Fumagalli, et al.
Cancer Research|October 5, 2001
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B studyS P Whitman, K J Archer, L Feng, et al.
The Journal of General Physiology|November 19, 2020
Different arrhythmia-associated calmodulin mutations have distinct effects on cardiac SK channel regulationHannah A Ledford, Seojin Park, Duncan Muir, et al.
Vaccine|October 14, 2015
Preclinical and clinical development of a dengue recombinant subunit vaccineSusan B Manoff, Sarah L George, Andrew J Bett, et al.
Blood|November 15, 1993
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583H Ozer, S L George, C A Schiffer, et al.
Gut Microbes|March 19, 2014
Early life establishment of site-specific microbial communities in the gutJoann Romano-Keeler, Daniel J Moore, Chunlin Wang, et al.
Stem Cell Reports|January 14, 2020
Negligible-Cost and Weekend-Free Chemically Defined Human iPSC CultureHui-Hsuan Kuo, Xiaozhi Gao, Jean-Marc DeKeyser, et al.
Elife|February 5, 2021
Dyshomeostatic modulation of Ca<sup>2+</sup>-activated K<sup>+</sup> channels in a human neuronal model of KCNQ2 encephalopathyDina Simkin, Kelly A Marshall, Carlos G Vanoye, et al.
Brain : a Journal of Neurology|April 23, 2024
Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disordersAnne T Berg, Christopher H Thompson, Leah Schust Myers, et al.
Cancer Research Communications|February 21, 2022
HSP70 inhibition blocks adaptive resistance and synergizes with MEK inhibition for the treatment of NRAS-mutant melanomaJoshua L D Parris, Thibaut Barnoud, Julia I-Ju Leu, et al.
Pageof 135